The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C

BACKGROUND: Arginine auxotrophy constitutes a shortcoming for ~ 30% of glioblastoma multiforme (GBM). Indeed, arginine-depleting therapy using arginine deiminase from Streptococcus pyogenes (SpyADI) has proven activity against GBM in preclinical studies. The good safety profile of SpyADI renders thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Linke, Charlotte, Freitag, Thomas, Riess, Christin, Scheffler, Jana Vanessa, del Moral, Katharina, Schoenwaelder, Nina, Fiedler, Tomas, Fiebig, Adina, Kaps, Philipp, Dubinski, Daniel, Schneider, Björn, Bergmann, Wendy, Classen, Carl Friedrich, Maletzki, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969664/
https://www.ncbi.nlm.nih.gov/pubmed/36843002
http://dx.doi.org/10.1186/s12935-023-02873-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969664/
https://www.ncbi.nlm.nih.gov/pubmed/36843002
http://dx.doi.org/10.1186/s12935-023-02873-2

Ejemplares similares